The Danish company Novo Nordisk announced its plans to cut around 9,000 jobs on Wednesday.

I dipendenti di Novo avevano previsto tagli di posti di lavoro da quando Mike Doustdar ha assunto la carica di amministratore delegato il mese scorso

Novo Nordisk, which produces Wegovy and Ozempic, said roughly 9,000 roles would be cut, with 5,000 of these reductions expected in Denmark.

El fabricante del Ozempic señala que Dinamarca será el país más afectado. La compañía acaba de nombrar a un nuevo CEO

Il gruppo stima che la riduzione del personale porterà a un risparmio annuo di 8 miliardi di corone (1,07 miliardi di euro) entro la fine del 2026

The Danish firm, which also produces Wegovy, has warned of increased pressure from "knock-off" drugs.

The Danish drugmaker said it needed to streamline operations and become more agile, as it faces a more competitive and consumer-focused market.

The Danish company Novo Nordisk announced its plans to cut around 9,000 jobs on Wednesday.

The Wegovy obesity drug maker on Wednesday announced plans to trim 11.5% of its workforce.

Danish manufacturer of weight-loss and diabetes drugs under pressure from US rival Eli Lilly

The layoffs come amid sluggish sales as competition heats up in the weight-loss drug market.

Il colosso danese licenzia l'11,5% degli addetti. Pesa la concorrenza di Eli Lilly nel mercato dei farmaci anti-obesità